Medistim ASA (MEDI)

Currency in NOK
214.00
-6.00(-2.73%)
Closed·
MEDI Scorecard
Full Analysis
Trading at a high earnings multiple
MEDI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
214.00224.00
52 wk Range
130.00237.00
Key Statistics
Prev. Close
214
Open
224
Day's Range
214-224
52 wk Range
130-237
Volume
3.92K
Average Volume (3m)
6.23K
1-Year Change
26.63%
Book Value / Share
25.53
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MEDI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
225.00
Upside
+5.14%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Medistim ASA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Medistim ASA Company Profile

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Employees
154
Market
Norway

Medistim ASA Earnings Call Summary for Q1/2025

  • Revenue grew 35.7% (31.8% currency-neutral), operating profit up 84% YoY, EPS increased 78%
  • Stock surged 17.85% post-earnings, nearing 52-week high; strong investor confidence
  • Robust growth across regions, particularly Americas and Asia Pacific; vascular and imaging portfolios excelled
  • Anticipates 8-10% quarterly growth; potential margin pressure from new US tariffs
  • Intui software launch in Q2 2025 expected to drive further revenue growth
Last Updated: 09/05/2025, 08:50
Read Full Transcript

Compare MEDI to Peers and Sector

Metrics to compare
MEDI
Peers
Sector
Relationship
P/E Ratio
33.3x20.1x−0.5x
PEG Ratio
1.650.030.00
Price/Book
8.8x3.6x2.6x
Price / LTM Sales
6.8x4.6x3.2x
Upside (Analyst Target)
2.3%13.9%42.7%
Fair Value Upside
Unlock9.2%5.8%Unlock

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 225.00
(+5.14% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.71%
Dividend Yield
2.80%
Industry Median 2.42%
Annualised payout
6.00
Paid annually
5-Years Growth
+16.89%
Growth Streak

Earnings

Latest Release
May 09, 2025
EPS / Forecast
2.37 / 1.47
Revenue / Forecast
182.00M / 138.00M
EPS Revisions
Last 90 days

MEDI Income Statement

People Also Watch

1,754.000
RHMG
-3.36%
423.9
NOVOb
+3.16%
98.7
BIOGb
-1.10%
380.40
VITb
-2.06%

FAQ

What Stock Exchange Does Medistim Trade On?

Medistim is listed and trades on the Oslo Stock Exchange stock exchange.

What Is the Stock Symbol for Medistim?

The stock symbol for Medistim is "MEDI."

What Is the Medistim Market Cap?

As of today, Medistim market cap is 3.91B.

What Is Medistim's Earnings Per Share (TTM)?

The Medistim EPS (TTM) is 6.71.

When Is the Next Medistim Earnings Date?

Medistim will release its next earnings report on 19 Aug 2025.

From a Technical Analysis Perspective, Is MEDI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Medistim Stock Split?

Medistim has split 0 times.

How Many Employees Does Medistim Have?

Medistim has 154 employees.

What is the current trading status of Medistim (MEDI)?

As of 23 Jul 2025, Medistim (MEDI) is trading at a price of 214.00, with a previous close of 214.00. The stock has fluctuated within a day range of 214.00 to 224.00, while its 52-week range spans from 130.00 to 237.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.